Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

The expanding roles of microRNAs in kidney pathophysiology.

Metzinger-Le Meuth V, Fourdinier O, Charnaux N, Massy ZA, Metzinger L.

Nephrol Dial Transplant. 2019 Jan 1;34(1):7-15. doi: 10.1093/ndt/gfy140.

PMID:
29800482
2.

Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses.

Marinval N, Morenc M, Labour MN, Samotus A, Mzyk A, Ollivier V, Maire M, Jesse K, Bassand K, Niemiec-Cyganek A, Haddad O, Jacob MP, Chaubet F, Charnaux N, Wilczek P, Hlawaty H.

Biomaterials. 2018 Jul;172:14-29. doi: 10.1016/j.biomaterials.2018.01.054. Epub 2018 Mar 16.

PMID:
29715592
3.

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.

Suffee N, Le Visage C, Hlawaty H, Aid-Launais R, Vanneaux V, Larghero J, Haddad O, Oudar O, Charnaux N, Sutton A.

Sci Rep. 2017 Oct 16;7(1):13294. doi: 10.1038/s41598-017-13444-7.

4.

Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.

Fysekidis M, Cosson E, Takbou K, Sutton A, Charnaux N, Banu I, Vicaut E, Valensi P.

Microvasc Res. 2018 Mar;116:6-14. doi: 10.1016/j.mvr.2017.09.005. Epub 2017 Sep 24.

PMID:
28954218
5.

Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.

Marinval N, Saboural P, Haddad O, Maire M, Bassand K, Geinguenaud F, Djaker N, Ben Akrout K, Lamy de la Chapelle M, Robert R, Oudar O, Guyot E, Laguillier-Morizot C, Sutton A, Chauvierre C, Chaubet F, Charnaux N, Hlawaty H.

Mar Drugs. 2016 Oct 17;14(10). pii: E185.

6.

Plasma vitamin D status and recurrent depressive symptoms in the French SU.VI.MAX cohort.

Collin C, Assmann KE, Deschasaux M, Andreeva VA, Lemogne C, Charnaux N, Sutton A, Hercberg S, Galan P, Touvier M, Kesse-Guyot E.

Eur J Nutr. 2017 Oct;56(7):2289-2298. doi: 10.1007/s00394-016-1269-y. Epub 2016 Jul 27.

PMID:
27464883
7.

Quick and Easy Screening for Vitamin D Insufficiency in Adults: A Scoring System to Be Implemented in Daily Clinical Practice.

Deschasaux M, Souberbielle JC, Andreeva VA, Sutton A, Charnaux N, Kesse-Guyot E, Latino-Martel P, Druesne-Pecollo N, Szabo de Edelenyi F, Galan P, Hercberg S, Ezzedine K, Touvier M.

Medicine (Baltimore). 2016 Feb;95(7):e2783. doi: 10.1097/MD.0000000000002783.

8.

Weight Status and Alcohol Intake Modify the Association between Vitamin D and Breast Cancer Risk.

Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M.

J Nutr. 2016 Mar;146(3):576-85. doi: 10.3945/jn.115.221481. Epub 2016 Jan 27.

PMID:
26817718
9.

A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.

Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M.

Br J Nutr. 2016 Jan 28;115(2):305-14. doi: 10.1017/S0007114515004353. Epub 2015 Nov 16.

PMID:
26568368
10.

Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Haddad O, Guyot E, Marinval N, Chevalier F, Maillard L, Gadi L, Laguillier-Morizot C, Oudar O, Sutton A, Charnaux N, Hlawaty H.

Mar Drugs. 2015 Oct 28;13(11):6588-608. doi: 10.3390/md13116588.

11.

Prospective associations between vitamin D status, vitamin D-related gene polymorphisms, and risk of tobacco-related cancers.

Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M.

Am J Clin Nutr. 2015 Nov;102(5):1207-15. doi: 10.3945/ajcn.115.110510. Epub 2015 Oct 7.

PMID:
26447153
12.

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress.

Mondadori dos Santos A, Metzinger L, Haddad O, M'baya-Moutoula E, Taïbi F, Charnaux N, Massy ZA, Hlawaty H, Metzinger-Le Meuth V.

Biomed Res Int. 2015;2015:497280. doi: 10.1155/2015/497280. Epub 2015 Jun 28.

13.

Comparative toxicity evaluation of flower-shaped and spherical gold nanoparticles on human endothelial cells.

Sultana S, Djaker N, Boca-Farcau S, Salerno M, Charnaux N, Astilean S, Hlawaty H, de la Chapelle ML.

Nanotechnology. 2015 Feb 6;26(5):055101. doi: 10.1088/0957-4484/26/5/055101. Epub 2015 Jan 9.

PMID:
25573907
14.

RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Maillard L, Saito N, Hlawaty H, Friand V, Suffee N, Chmilewsky F, Haddad O, Laguillier C, Guyot E, Ueyama T, Oudar O, Sutton A, Charnaux N.

Biol Open. 2014 Sep 26;3(10):995-1004. doi: 10.1242/bio.20148227.

15.

Determinants of vitamin D status in Caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors.

Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Assmann KE, Fezeu L, Latino-Martel P, Druesne-Pecollo N, Guinot C, Latreille J, Malvy D, Galan P, Hercberg S, Le Clerc S, Souberbielle JC, Ezzedine K.

J Invest Dermatol. 2015 Feb;135(2):378-388. doi: 10.1038/jid.2014.400. Epub 2014 Sep 11.

16.

Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes.

Julia C, Czernichow S, Charnaux N, Ahluwalia N, Andreeva V, Touvier M, Galan P, Fezeu L.

Diabetes Res Clin Pract. 2014 Aug;105(2):231-8. doi: 10.1016/j.diabres.2014.05.001. Epub 2014 May 17.

PMID:
24931702
17.

Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.

Tarhuni A, Guyot E, Rufat P, Sutton A, Bourcier V, Grando V, Ganne-Carrié N, Ziol M, Charnaux N, Beaugrand M, Moreau R, Trinchet JC, Mansouri A, Nahon P.

J Hepatol. 2014 Aug;61(2):342-50. doi: 10.1016/j.jhep.2014.04.011. Epub 2014 Apr 18.

PMID:
24751829
18.

Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.

Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D, Galan P, Hercberg S, Ezzedine K, Souberbielle JC.

J Clin Endocrinol Metab. 2014 Apr;99(4):1196-203. doi: 10.1210/jc.2013-3349. Epub 2014 Feb 14.

PMID:
24527713
19.

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.

Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc JF, Sturm N, Bioulac-Sage P, Nahon P, Nault JC, Charnaux N, N'kontchou G, Trinchet JC, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-Carrié N.

J Hepatol. 2013 Dec;59(6):1264-70. doi: 10.1016/j.jhep.2013.07.030. Epub 2013 Aug 6.

PMID:
23928407
20.

Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.

Nault JC, Guyot E, Laguillier C, Chevret S, Ganne-Carrie N, N'Kontchou G, Beaugrand M, Seror O, Trinchet JC, Coelho J, Lasalle P, Charnaux N, Delehedde M, Sutton A, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1343-52. doi: 10.1158/1055-9965.EPI-13-0179. Epub 2013 Jun 18.

21.

Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.

Cosson E, Banu I, Cussac-Pillegand C, Chen Q, Chiheb S, Jaber Y, Nguyen MT, Charnaux N, Valensi P.

Diabetes Care. 2013 Jul;36(7):2070-6. doi: 10.2337/dc12-1780. Epub 2013 Feb 1.

22.

Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects.

Cosson E, Chiheb S, Cussac-Pillegand C, Banu I, Hamo-Tchatchouang E, Nguyen MT, Aout M, Charnaux N, Valensi P.

Diabetes Metab. 2013 Apr;39(2):118-25. doi: 10.1016/j.diabet.2012.08.013. Epub 2012 Dec 4.

PMID:
23219071
23.

Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.

Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Méjean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S.

Am J Epidemiol. 2013 Jan 1;177(1):3-13. doi: 10.1093/aje/kws359. Epub 2012 Nov 20.

24.

PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.

Guyot E, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Beaugrand M, Charnaux N, Trinchet JC, Nahon P.

J Hepatol. 2013 Feb;58(2):312-8. doi: 10.1016/j.jhep.2012.09.036. Epub 2012 Oct 13.

PMID:
23069476
25.

Limited value of angiogenic factors in obese women.

Loire P, Vicaut E, Cruaud P, Charnaux N, Carbillon L.

Pregnancy Hypertens. 2012 Oct;2(4):368-70. doi: 10.1016/j.preghy.2012.06.001. Epub 2012 Jul 13.

PMID:
26105604
26.

RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.

Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A.

Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.

PMID:
22752444
27.

Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk.

Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Méjean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S.

World J Gastroenterol. 2012 Jun 14;18(22):2805-12. doi: 10.3748/wjg.v18.i22.2805.

28.

Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.

Briane D, Slimani H, Tagounits A, Naejus R, Haddad O, Coudert R, Charnaux N, Cao A.

J Drug Target. 2012 May;20(4):347-54. doi: 10.3109/1061186X.2012.656645.

PMID:
22475204
29.

Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study.

Touvier M, Kesse-Guyot E, Andreeva VA, Fezeu L, Charnaux N, Sutton A, Druesne-Pecollo N, Hercberg S, Galan P, Zelek L, Latino-Martel P, Czernichow S.

Am J Clin Nutr. 2012 Apr;95(4):944-50. doi: 10.3945/ajcn.111.027805. Epub 2012 Feb 29.

PMID:
22378736
30.

Angiogenic properties of the chemokine RANTES/CCL5.

Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A.

Biochem Soc Trans. 2011 Dec;39(6):1649-53. doi: 10.1042/BST20110651. Review.

PMID:
22103502
31.

A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.

Nahon P, Sutton A, Rufat P, Charnaux N, Mansouri A, Moreau R, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Pessayre D, Beaugrand M.

J Hepatol. 2012 Feb;56(2):426-32. doi: 10.1016/j.jhep.2011.08.010. Epub 2011 Sep 8.

PMID:
21907168
32.

Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.

Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1439-46. doi: 10.1158/1055-9965.EPI-11-0341. Epub 2011 May 24.

33.

What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?

Cosson E, Nguyen MT, Hamo-Tchatchouang E, Banu I, Chiheb S, Charnaux N, Valensi P.

Diabet Med. 2011 May;28(5):567-74. doi: 10.1111/j.1464-5491.2010.03215.x.

PMID:
21480967
34.

Manganese superoxide dismutase dimorphism relationship with severity and prognosis in cardiogenic shock due to dilated cardiomyopathy.

Charniot JC, Sutton A, Bonnefont-Rousselot D, Cosson C, Khani-Bittar R, Giral P, Charnaux N, Albertini JP.

Free Radic Res. 2011 Apr;45(4):379-88. doi: 10.3109/10715762.2010.532792. Epub 2010 Nov 10.

PMID:
21062213
35.

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V, Laguillier-Morizot C, Gattegno L, Letourneur D, Charnaux N.

Biochem Pharmacol. 2011 Jan 15;81(2):233-43. doi: 10.1016/j.bcp.2010.09.021. Epub 2010 Sep 29.

PMID:
20887714
36.

Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis?

Nahon P, Sutton A, Pessayre D, Rufat P, Charnaux N, Trinchet JC, Beaugrand M, Deugnier Y.

Antioxid Redox Signal. 2011 Jul 1;15(1):31-8. doi: 10.1089/ars.2010.3529. Epub 2010 Nov 30.

PMID:
20673159
37.

Microvascular dysfunction in healthy insulin-sensitive overweight individuals.

Czernichow S, Greenfield JR, Galan P, Bastard JP, Charnaux N, Samaras K, Safar ME, Blacher J, Hercberg S, Levy BI.

J Hypertens. 2010 Feb;28(2):325-32. doi: 10.1097/HJH.0b013e328333d1fc.

PMID:
20051903
38.

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, Charnaux N, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Gattegno L, Pessayre D, Beaugrand M.

Hepatology. 2009 Nov;50(5):1484-93. doi: 10.1002/hep.23187.

PMID:
19731237
39.

Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.

Friand V, Haddad O, Papy-Garcia D, Hlawaty H, Vassy R, Hamma-Kourbali Y, Perret GY, Courty J, Baleux F, Oudar O, Gattegno L, Sutton A, Charnaux N.

Glycobiology. 2009 Dec;19(12):1511-24. doi: 10.1093/glycob/cwp130. Epub 2009 Aug 28.

PMID:
19717493
40.

Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells.

Brule S, Friand V, Sutton A, Baleux F, Gattegno L, Charnaux N.

Biochim Biophys Acta. 2009 Dec;1790(12):1643-50. doi: 10.1016/j.bbagen.2009.08.001. Epub 2009 Aug 17.

PMID:
19695308
41.

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO, Gattegno L, Oudar O, Sutton A, Charnaux N.

Int J Cancer. 2010 Mar 1;126(5):1095-108. doi: 10.1002/ijc.24800.

42.

Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.

Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A.

Biochim Biophys Acta. 2009 Oct;1790(10):1314-26. doi: 10.1016/j.bbagen.2009.07.015. Epub 2009 Jul 24.

PMID:
19632304
43.

Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights.

Albanese P, Caruelle D, Frescaline G, Delbé J, Petit-Cocault L, Huet E, Charnaux N, Uzan G, Papy-Garcia D, Courty J.

Exp Hematol. 2009 Sep;37(9):1072-83. doi: 10.1016/j.exphem.2009.06.005. Epub 2009 Jun 17.

PMID:
19539688
44.

Capillary endothelial but not lymphatic function is restored under rosiglitazone in Zucker diabetic fatty rats.

Cosson E, Cohen-Boulakia F, Tarhzaoui K, Dabiré H, Léger G, Charnaux N, Lestrade R, Behar A, Valensi P.

Microvasc Res. 2009 Mar;77(2):220-5. doi: 10.1016/j.mvr.2008.11.005. Epub 2008 Dec 3.

PMID:
19109983
45.

Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.

Fermas S, Gonnet F, Sutton A, Charnaux N, Mulloy B, Du Y, Baleux F, Daniel R.

Glycobiology. 2008 Dec;18(12):1054-64. doi: 10.1093/glycob/cwn088. Epub 2008 Sep 16.

PMID:
18796646
46.

The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells.

Nahon P, Charnaux N, Friand V, Prost-Squarcioni C, Ziol M, Lièvre N, Trinchet JC, Beaugrand M, Gattegno L, Pessayre D, Sutton A.

Free Radic Biol Med. 2008 Nov 1;45(9):1308-17. doi: 10.1016/j.freeradbiomed.2008.08.011. Epub 2008 Aug 15.

PMID:
18760346
47.

Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.

Nahon P, Sutton A, Rufat P, Simon C, Trinchet JC, Gattegno L, Beaugrand M, Charnaux N.

World J Gastroenterol. 2008 Feb 7;14(5):713-9.

48.

Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, Schischmanoff PO, Vidaud D, Charnaux N, Couvert P, Ganne-Carrie N, Trinchet JC, Gattegno L, Beaugrand M.

Gastroenterology. 2008 Jan;134(1):102-10. Epub 2007 Oct 26.

49.

Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.

Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, Vassy R, Haddad O, Sainte-Catherine O, Kraemer M, Saffar L, Perret GY, Courty J, Gattegno L, Charnaux N.

Mol Cancer Ther. 2007 Nov;6(11):2948-58.

50.

Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.

Nahon P, Sutton A, Rufat P, Faisant C, Simon C, Barget N, Trinchet JC, Beaugrand M, Gattegno L, Charnaux N.

Eur J Gastroenterol Hepatol. 2007 May;19(5):425-31.

PMID:
17413295

Supplemental Content

Loading ...
Support Center